baber/WOPTO huggingface dataset:
Patent NZ-582209-A (NZ)
Title: Acyloxyalkyl carbamate prodrugs, methods of synthesis and use
Inventor: GALLOP MARK A
IPC: C07C271/22
Filed: 2004-08-20
Abstract: Disclosed is a compound of formula (I), pharmaceutically acceptable salts, hydrates or solvates thereof, or isomers of any of the foregoing, that are useful for treating or preventing diseases such as spasticity and acid reflux disease, wherein the substituents are defined as following: R1 is selected from the group consisting of acyl, substituted acyl, alkyl, substituted alkyl, aryl, substituted aryl, arylalkyl, substituted arylalkyl, cycloalkyl, substituted cycloalkyl, cycloheteroalkyl, substituted cycloheteroalkyl, heteroalkyl, substituted heteroalkyl, heteroaryl, substituted heteroaryl, heteroarylalkyl and substituted heteroarylalkyl; R2 is selected from the group consisting of alkyl, substituted alkyl, alkoxycarbonyl, substituted alkoxycarbonyl, aryl, substituted aryl, arylalkyl, substituted arylalkyl, cycloalkyl, substituted cycloalkyl, heteroaryl, substituted heteroaryl, heteroarylalkyl and substituted heteroarylalkyl or optionally, R 2 and R3 together with the carbon atom to which they are bonded form a cycloalkyl, substituted cycloalkyl, cycloheteroalkyl or substituted cycloheteroalkyl ring; R3 is hydrogen;R4 is selected from the group consisting of hydrogen, alkyl, substituted alkyl, aryl, substituted aryl, arylalkyl, substituted arylalkyl, aryldialkylsilyl, cycloalkyl, substituted cycloalkyl, cycloheteroalkyl, substituted cycloheteroalkyl, heteroalkyl, substituted heteroalkyl, heteroaryl, substituted heteroaryl, heteroarylalkyl, substituted heteroarylalkyl or trialkylsilyl; and R5 is 4-fluorophenyl.
Patent NZ-591671-A (NZ)
Title: Producing electromagnetic fields for transferring electric energy to a vehicle
Inventor: VOLLENWYDER KURT
IPC: B60L5/00
Filed: 2009-09-17
Abstract: A system and a method for transferring electric energy to a vehicle, in particular to a track bound vehicle such as a light rail vehicle are disclosed. The system comprises an electric conductor arrangement for producing an alternating electromagnetic field and for thereby transferring the energy to the vehicle. The electric conductor arrangement comprises at least one alternating current line and each alternating current line is adapted to carry one phase of an alternating electric current. The conductor arrangement comprises a plurality of consecutive segments and a direct current supply line. The segments extend along the path of travel of the vehicle and each segment comprises one section of each of the at least one alternating current line. The direct current supply line is for supplying electric energy to the segments. Each segment is connected to the supply line via at least two inverter which is adapted to invert a direct current carried by the supply line to an alternating current carried by the at least one alternating current line. The first inverter connects the supply line to a first end of the section(s) of a segment and the second inverter connects the supply line to a second end of the section(s) of the same segment or of the section(s) of a consecutive row of segments. The first end and the second end are opposite ends of the segment or of the row of segments, and the system is adapted to operate the first inverter and the second inverter at a predefined phase shift relative to each other, thereby producing an alternating voltage across the segment or row of segments, which alternating voltage causes a corresponding alternating current to flow through the segment or row of segments.
Patent NZ-597477-A (NZ)
Title: Tetracyclic compounds
Inventor: SAKAMOTO HIROSHI
IPC: A61K31/343
Filed: 2010-06-09
Abstract: 597477 Provided is a therapeutic and preventive agent effective against diseases accompanied by an abnormality of ALK, such as cancers, cancerous metastases, depression, or cognitive dysfunction, the agent containing an ALK-inhibitory compound. The agent comprises a medicinal composition containing a compound represented by general formula (I), wherein the variables are defined in the specification, a salt of the compound, or a solvate of either. In one embodiment the compound is 9-(4-isopropyl-piperazin-1-yl)-6,6-dimethyl-11-oxo-6,11-dihydro-5H-benzo[b]carbazole-3-carbonitrile.
Patent NZ-598006-A (NZ)
Title: Intraocular lenses with interlenticular opacification resistance
Inventor: TSAI CHI-CHUN
IPC: A61F2/16
Filed: 2010-09-02
Abstract: 598006 The present invention is directed to an intraocular lens, an intraocular lens system (10) and a method of producing the lens or system. The system comprises a set (12, 14) of dual optic intraocular lenses or piggyback lenses. At least one lens (12, 14) is made of a hydrophobic material (18) and includes a coating (24) that aids in resisting interlenticular opacification (ILO). The material of the coating (24) is either hydrophilic or super-hydrophobic relative to the lens body (18).
Patent NZ-605677-A (NZ)
Title: Device and method for hspa wcdma uplink pilots
Inventor: LARSSON ERIK
IPC: H04B7/06
Filed: 2011-08-18
Abstract: Disclosed is a User Equipment (UE (115)), for an HSPA enabled WCDMA system (100). The UE (115) is equipped with at least a first (111) and a second (112) transmit antenna and is arranged to use one or more sets of pre-coding weights. Each pre-coding weight is the one or more sets to be used by the UE (115) for multiplication with information which is transmitted from one of the UE’s antennas (111,112). The UE (115) is further arranged to receive instructions from a NodeB (105) on the set or sets of pre-coding weights to be used via radio resource signalling. The UE (115) transmits a first and a second pilot signal, and uses a first set of pre-coding weights for the first pilot signal and a second set of pre-coding weights for the second pilot signal. The first set of pre-coding weights is the same that the UE (115) uses for transmitting a first data stream, different spreading codes are used for the first data stream and for the first pilot signal. An output power of the second pilot signal is offset relative to an output power of the first pilot signal. The NodeB (105) for carrying out the method is also disclosed.
Patent NZ-607473-A (NZ)
Title: Anti-cd38 antibody and lenalidomide or bortezomib for the treatment of multiple myeloma and nhl
Inventor: ROJKJAER LISA
IPC: C07K16/28
Filed: 2011-09-26
Abstract: Disclosed is a composition comprising an antibody specific for CD38 comprising an HCDR1 region of sequence SYYMN (SEQ ID NO: 14), an HCDR2 region of sequence GISGDPSNTYYADSVKG (SEQ ID NO: 2), an HCDR3 of sequence DLPLVYTGFAY (SEQ ID NO: 3), an LCDR1 region of sequence SGDNLRHYYVY (SEQ ID NO: 4), an LCDR2 region of sequence GDSKRPS (SEQ ID NO: 5), and an LCDR3 region of sequence QTYTGGASL (SEQ ID NO: 6); and either (a) thalidomide, a thalidomide analogue, lenalidomide, or pomalidomide, or (b) bortezomib, for use in the treatment of multiple myeloma and/or non-hodgkins lymphoma.
Patent NZ-618756-A (NZ)
Title: Direct drive rotary wave energy conversion
Inventor: LAMB BRADFORD
IPC: F03B13/20
Filed: 2010-02-22
Abstract: An apparatus and method for converting wave energy using the relative rotational movement between two interconnected float assemblies. The wave energy converter has a first and second float as well as a first and second float bearing serving to connect the first float to the second float such that the floats are capable of relative rotational movement about an axis of rotation. The first and second float are constructed so as to define a central opening when connected. The wave energy converter has a spar with a top end terminating in a motor housing and a bottom end, the motor housing defines a watertight interior. The motor housing including at least two sealed bearings, one on opposite side walls of the motor housing. The wave energy converter has a rotational power take off disposed within the motor housing water tight interior. The wave energy converter has a first drive shaft rotatably supported by one of the at least two sealed bearings operatively connecting the first float to the mechanical power take off. Rotation of the first float about the axis of rotation causes the first drive shaft to rotate. The wave energy convertor has a second drive shaft rotatably supported by one of the at least two sealed bearings operatively connecting the second float to the mechanical power take off. Rotation of the second float about the axis of rotation causes the drive shaft to rotate. The spar nests within the central opening defined between the first float and the second float and supporting the first float and the second float through the first drive shaft and the second drive shaft. The spar bottom end extends into a body of water while the first float and the second float are supported at water surface and wave heave and wave thrust of the body of water cause the spar, the first float, and the second float to rotate relative to one another about the axis of rotation, so as to deliver rotational energy to said power take off within the motor housing.
Patent NZ-622967-A (NZ)
Title: Payment requests
Inventor: WILLIAMS RICHARD MARK
IPC: G06Q40/00
Filed: 2011-09-30
Abstract: The disclosure concerns computing systems that support payments between two users. When implemented as a computer (105) the computer (105) facilitates P2P- payment. The computer (105) receives from a payee (103) or a payee FI (104) a payment request. The payment request includes a payer identifier, a payee identifier and payment information. The computer (105) then determines a payer FI (102) and sends the payment request to the payer FI (102) to cause the payer FI (102) to notify the payer (101) of the payment request and to enable the payer (101) to confirm payment. The computer 105 receives from the payer FI (102) a payment notification for the payment and sends the payment notification to the payee FI (104). The payer (101) and the payee (103) are not required to open a new account at a third party system but the funds are transferred directly from the payer FI (101) to the payee FI (103).
Patent NZ-625595-A (NZ)
Title: Method for highly expressing recombinant protein in recombinant bacteria and use thereof
Inventor: QIU XIAOQING
IPC: C12R1/19
Filed: 2012-11-23
Abstract: Disclosed is a method for highly expressing a recombinant protein in recombinant bacteria, wherein the recombinant protein comprises a hydrophilic and a hydrophobic end, wherein the hydrophilic end is a colicin polypeptide and wherein the hydrophobic end is a polypeptide target moiety which is capable of binding a target, the method comprising: (1) transfecting a recombinant plasmid expressing the recombinant protein into E.coli bacteria with pET system to obtain positive monoclonal colonies and produce recombinant E.coli bacteria, (2) producing seed bacteria solution from the positive monoclonal colonies, and inducing protein expression and enlargement culturing of the seed bacteria solution in enlargement culturing medium; wherein the supernatant of the enlargement cultured solution contains the expressed recombinant protein, (3) extracting and purifying the recombinant protein from the supernatant, wherein the recombinant E.coli bacteria with pET system is E.coli B834 (DE3), and wherein the enlargement culturing medium has water as solvent and comprises the following components: NaCl 6.0~6.7 g/L, peptone 25.0 g/L, yeast powder 7.5 g/L, glucose 0.6~2.0 g/L, Na2HPO4·7H2O 6.8~18.3 g/L, KH2PO4 3.0~4.3 g/L, NH4Cl 1.0~1.4 g/L, MgSO4 0.2~0.4 g/L, CaCl2 0.01 g/L, and methionine 0~40 mg/L. Also disclosed is a medium for recombinant E. Coli bacteria with pET system. wherein the medium has water as solvent and comprises the following components: NaCl 6.0~6.7 g/L, peptone 25.0 g/L, yeast powder 7.5 g/L, glucose 0.6~2.0 g/L, Na2HPO4·7H2O 6.8~18.3 g/L, KH2PO4 3.0~4.3 g/L, NH4Cl 1.0~1.4 g/L, MgSO4 0.2~0.4 g/L, CaCl2 0.01 g/L, and methionine 0~40 mg/L.
Patent NZ-625855-A (NZ)
Title: Method and apparatus for visualizing and interacting with decision trees
Inventor: DONALDSON J JUSTIN
IPC: G06F17/30
Filed: 2012-11-02
Abstract: Disclosed is a method for visualising and interacting with decision trees generated from sample data. The method comprises identifying characteristics associated with the decision tree; and filtering out portions of the decision tree based on the characteristics. The decision tree comprises nodes and branches and filtering the decision tree model comprises filtering out some of the nodes (124) and branches (126) based on the characteristics of the decision tree associated with the nodes or branches. The process includes filtering a first set of nodes (124) from the decision tree and displaying a second set of remaining nodes (122) corresponds to most significant portions of the decision tree. The process also includes receiving an input identifying a selected one of the second set of remaining nodes; and displaying child nodes from the first set of nodes for the selected one of the second set of remaining nodes.
Patent NZ-701861-A (NZ)
Title: Lock assembly with electrically controlled lock mechanism
Inventor: DAVID NIE
IPC: E05B63/08
Filed: 2014-11-11
Abstract: This invention relates to a lock assembly 2 for installation in a door, including a latch bolt 23, a lock means 28 including electrically operated detent mechanism 40 with a rechargeable energy storage device 29 being the only supply of energy to the electrically operated detent means 40. The rechargeable energy storage device 29 is connected in use to a source of energy remote from the door. A problem with a lock assembly 2 having an electrically operable detent mechanism 40 can occur where multiple lock assemblies 2 are connected to the same remote energy source. The multiple lock assemblies can draw significant current so as to require wiring of greater capacity to support the multiple lock assemblies. A solution to this is to include an energy storage device in the lock assembly itself that is fed by the remote source of energy.
Patent NZ-709407-A (NZ)
Title: Azole benzene derivative
Inventor: SHIRAKURA TAKASHI
IPC: C07D417/10
Filed: 2014-01-30
Abstract: The present invention provides: a compound represented by formula (I) or a pharmaceutically acceptable salt thereof, which has an inhibitory activity on xanthine oxidase and is useful as a therapeutic agent or a prophylactic agent for diseases associated with xanthine oxidase, such as gout, hyperuricemia, tumor lysis syndrome, urinary tract stone, hypertension, dyslipidemia, diabetes, cardiovascular diseases including arteriosclerosis and heart failure, renal diseases including diabetic nephropathy, respiratory diseases including chronic obstructive pulmonary disease, inflammatory bowel disease or autoimmune diseases; and a medicine or a pharmaceutical composition comprising the compound or the salt as an active ingredient.
Patent NZ-712184-A (NZ)
Title: Combination therapy comprising a b-raf inhibitor and a second inhibitor
Inventor: CAPONIGRO GIORDANO
IPC: A61P35/00
Filed: 2014-03-19
Abstract: The Application relates to the use of a B-Raf inhibitor in combination with a second inhibitor for the treatment of a patient suffering from a proliferative disease characterized by mutation in BRAF. Namely, the invention relates to reversing resistance to a B-Raf inhibitor for the treatment of a proliferative disease by obtaining a tumor sample from the patient and testing it for genetic alterations in a panel of genes comprising BRAF, CRAF, MAP2K1, MAP2K2, NRAS, KRAS HRAS, and EGFR and administering a drug combination therapy comprising a B-Raf inhibitor of formula (I) and a Mek 1/2 inhibitor which is Compound B, which overcomes resistance to the B-Raf inhibitor, which second inhibitor is selected based on genetic alterations discovered in the tumor sample.
Patent NZ-715430-A (NZ)
Title: Mammalian milk osteopontin for enhancing immune responsiveness
Inventor: WEJSE PETER LANGBORG
IPC: A61K38/17
Filed: 2014-07-04
Abstract: The disclosed invention provides mammalian milk osteopontin and/or an active truncation or active peptide thereof for improving immune responsiveness to an infectious disease in a human subject, as well as enhancing the efficacy of vaccination for the prophylactic or therapeutic treatment of an infectious disease in humans. The invention further provides a vaccine system, for use in the prophylactic or therapeutic treatment of an infectious disease in a human, comprising a vaccine and a mammalian milk osteopontin and/or an active truncation or active peptide thereof for oral administration to a human, as well as methods of enhancing immune resistance to an infectious disease in a human by administration of a vaccine and a mammalian milk osteopontin and/or an active truncation thereof.
Patent NZ-740023-A (NZ)
Title: Processing biomass
Inventor: MEDOFF MARSHALL
IPC: C12P19/02
Filed: 2010-05-18
Abstract: Irradiation of biomass with an electron beam and contacting with microorganisms such as for the purpose of fermentation. The disclosure includes a method of converting a low molecular weight sugar to a product utilising a microorganism and/or enzyme immobilised on a biomass material. The biomass material could comprise functionalised biomass fibres having a porosity of greater than 70%.
Patent NZ-755103-A (NZ)
Title: Remote administration of initial computer operating system setup options
Inventor: PURI NAMRATA
IPC: G06F21/12
Filed: 2018-02-20
Abstract: Remote administration of initial computer operating system setup options is facilitated by systems and mechanisms that provide such initial setup options to a computing device during an earlier stage of the operating system setup. An administrator defines, in a profile, how such initial setup options are to be set and when an operating system is being set up it communicates with licensing servers to validate the copy of the operating system. If authorized, and if set up by an administrator, initial setup options are provided to the computing device at such an early stage of the operating system setup. Processes executing on the computing device then utilize software licensing application program interfaces to not only validate the copy of the operating system, but also to set the initial setup options in the manner pre-specified by the administrator. A customized directory service login user interface is one such initial setup option. The initial operating system setup options are those operating system operations that the operating system requests a user to set prior to allowing the user to log on to a directory service via the customized directory sign-in and the subsequent operating system setup options are those operating system operations that are set in accordance with user specific settings provided based on the user’s login to the directory service.
Patent NZ-760819-A (NZ)
Title: Method for locating animals
Inventor: AUER WOLFGANGG
IPC: A01K29/00
Filed: 2015-02-12
Abstract: The invention relates to a method for locating animals with the aid of radio waves. In particular, the invention provides a method comprising: measuring, using a sensor, an acceleration of an animal; determining, using a data processing system, an activity of the animal using the measured acceleration; determining, using the data processing system, a height of a first node associated with the animal based on the activity; transmitting, using a radio location system, a signal; determining, using the radio location system, a distance between the first node and a second node of known position based on the signal; calculating, using the data processing system, a plurality of possible positions of the first node using the distance between the first node and the second node and the position of the second node; determining, using the data processing system, whether the first node and the second node are in a direct line of sight with each other; eliminating, using the data processing system, positions of the plurality of possible positions of the first node if the first node and the second node are not in direct line of sight with each other and the determined height is above a predetermined height; selecting, using the data processing system, out of the remaining plurality of possible positions the actual matching position of the first node; and locating the animal based on the position of the first node.
Patent NZ-764226-A (NZ)
Title: System and method for augmented and virtual reality
Inventor: MILLER SAMUEL
IPC: H04L69/14
Filed: 2012-10-29
Abstract: Disclosed is a head-mounted user display device comprises a display lens and a processor. The display lens reflects light toward a user’s eye and selectively allows transmission of light from an outside environment directly through the display lens. The processor is operatively coupled to the display lens and has software running thereon. When the processor executes the software, the processor directs the display lens to selectively allow transmission of light in response to selecting a visualization mode, and senses two or more individual physical objects using the environment sensing system. The light comprises a virtual object and renderings of the two or more individual physical objects. The visualization mode is selected from a group consisting of an augmented reality mode, a virtual reality mode, and a blended reality mode. The blended reality mode comprises rendering two or more individual physical objects sensed using an environment sensing system as individual virtual physical objects. The visualization mode comprises the blended reality mode. The blended reality mode comprises rendering individual physical objects sensed using an environment sensing system as individual virtual physical objects. The head-mounted user display device is configured for displaying one of a virtual object, a physical object, a virtual physical object, or any combination of virtual objects, physical objects, and virtual physical objects. The head-mounted user display device transmits the virtual object and the renderings of the two or more individual physical objects to a second head-mounted user display device in a second environment. The second head-mounted user display device projects second light toward a second display lens of the second head-mounted user display device and reflects the second light using the second display lens toward a second user’s eye. The second head-mounted user display device operates in the augmented reality mode or the virtual reality mode and displays at least the virtual object and the renderings of the two or more physical objects to the second user.
Patent PT-105315-A (PT)
Title: Uma nova forma cristalina hidratada de erbumina de perindopril, métodos para a sua preparação e sua utilização em preparações farmacêuticas
Inventor: SANTOS PEDRO PAULO DE LACERDA E OLIVEIRA
IPC: A61K31/403
Filed: 2010-09-29
Abstract: O OBJECTO DO INVENTO É UMA NOVA FORMA HIDRATADA DE ERBUMINA DE PERINDOPRIL (I) CARACTERIZADA POR DIFERENTES TÉCNICAS, INCLUINDO DIFRACÇÃO DE RAIOS-X EM PÓS E CRISTAL ÚNICO, SENDO ÚTIL NA PREPARAÇÃO DE PRODUTOS FARMACÊUTICOS. ESTA NOVA FORMA CRISTALINA PODE SER OBTIDA POR CRISTALIZAÇÃO DE SOLUÇÃO ALCOÓLICA OU DIRECTAMENTE A PARTIR DE OUTRAS FORMAS CRISTALINAS POR MOAGEM. TODOS OS PROCESSOS DE PREPARAÇÃO DESCRITOS PERMITEM OBTER A NOVA FORMA A PARTIR DE QUALQUER UMA DAS FORMAS POLIMÓRFICAS DE ERBUMINA DE PERINDOPRIL.